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The Next Steps in Developing
Clinical Practice Guidelines for Prevention
Gary H. Gibbons, MD,* John Gordon Harold, MD, MACC, MACP,yz Mariell Jessup, MD, FAHA,xjj
Rose Marie Robertson, MD, FAHA,jj William J. Oetgen, MD, MBA, MBA, FACC, FACPzFrom the National Heart, Lung, and Blood Institute
On June 19, 2013, we published in the online version of the
Journal an essay describing the National Heart, Lung, and
Blood Institute’s (NHLBI’s) change in approach to the
development of clinical practice guidelines (CPGs) (1). Over
the intervening weeks, we moved forward according to the
principles outlined in our essay. We have taken the critical
next steps to enable a more comprehensive evidence-based
review. This will lead to a process that will expeditiously
ﬁnalize the guidelines relevant to cardiovascular disease
prevention (hyperlipidemia, hypertension, cardiovascular risk
assessment, cardiovascular lifestyle interventions, and
obesity). Speciﬁcally, we have asked the American Heart
Association (AHA) and the American College of Cardiology
(ACC), jointly, to assume the governance and management
of these prevention guidelines and to ensure their completion
and dissemination to the public. We are pleased to announce
that they have agreed to do so. We are especially pleased that
they spontaneously voiced the desire to include and work with
stakeholder organizations, including those in our National
Program to Reduce Cardiovascular Risk, in alignment with
the collaborative model discussed in our essay.
Our choice of the ACC and the AHA is based on
a number of factors. We have had a solid relationship with
both organizations for many years and admire their effec-
tiveness in individual and joint CPG and performance
measure development and quality improvement; we are con-
ﬁdent that their long-standing work in these areas is moti-
vated by and devoted to improving the health of patients and
the public; we believe that their reputations and processes in
the development of guidelines and measures are of the
highest quality; and we have been impressed by their inclu-
siveness and collaborative nature. This last factor is especially
important to us, because we believe that an inclusive process
will be important to the broad endorsement, uptake, and
adoption of these important guidelines. We are happy to
continue as an active partner in the evidence review requiredFrom the *Ofﬁce of the Director of the National Heart, Lung, and Blood Institute,
National Institutes of Health, U.S. Department of Health and Human Services,
Bethesda, Maryland; yCedars-Sinai Medical Center, Los Angeles, California;
zAmerican College of Cardiology Foundation, Washington, DC; xUniversity of
Pennsylvania, Philadelphia, Pennsylvania; and the jjAmerican Heart Association,
Dallas, Texas.for the development of these prevention guidelines, and
believe that this new model will serve the public well.
From the American Heart Association/
American College of Cardiology
Speaking jointly, we are pleased and honored to be invited
by the NHLBI to partner with them and to assume the
responsibility for the 5 CPGs in cardiovascular prevention.
Our AHA and ACC volunteers have participated in the
development of NHLBI reports and guidelines for many
years. Moreover, our organizations have formally acknowl-
edged our respect for the NHLBI’s proud legacy in the
CPG development process by frequently synchronizing our
guidelines with information from their reports. Thus, we are
ready and willing to support the change in process an-
nounced by the NHLBI (1) on June 19, 2013, and to un-
dertake this very important work going forward.
We are very pleased that these guidelines will have, as
a critical base, the extensive work already done by the
current writing panels under the leadership of Dr. Sidney
Smith and the writing panel chairpersons. In addition, we
have a strong desire to include other organizations in this
effort, to ensure the optimal development as well as the
broad uptake and utilization of these guidelines. We believe
this will allow us all to take advantage of the extensive
experience that the ACC and AHA have in guidelines
development and to promote a transparent process that
recognizes the value and expertise of other professional
societies, as well as the highly valuable individual and group
efforts that have been expended in the development of the
current documents.
Recognizing the Institute of Medicine’s recommendation
that the CPG development process be bifurcated into the
generation of systematic reviews of the evidence (2), the
identiﬁcation of clinical questions, and the proffering of
clinical recommendations (3), we are utilizing these pro-
cesses in our own joint CPGs. Thus, we feel it is entirely
appropriate that the NHLBI has decided to focus its
resources and expertise on evaluation of the available
research evidence via the systematic review function, while
entrusting us with the processes leading to CPG develop-
ment. We believe that this will be an effective model for the
future.
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1400To address in more detail the current work in progress,
the NHLBI has, over the past 5 years, been supporting
a rigorous systematic review of the evidence relevant to
a number of clinical questions in the areas cited in the
previous text. To proceed as expeditiously as possible from
this point to the development of the ﬁnal CPGs, we have
committed our joint ACC/AHA Task Force on Practice
Guidelines to provide oversight and staff support, and the
NHLBI has committed to support further systematic
evidence review as needed. We are inviting all chairs and
members of the current writing panels to continue to work
together with us to ﬁnalize the guidelines. These individuals,
who have produced the current draft documents, include
experienced methodologists and expert clinicians and re-
searchers from a broad group of organizations (including
primary care providers, specialists, and patient advocates),
and their participation will be invaluable. In addition, we
welcome and will seek discussions with the stakeholder
organizations whose members or volunteers have been part
of the panels or who are part of the National Program to
Reduce Cardiovascular Risk, so that we can be as inclusive as
possible as these guidelines are developed.
The ACC and the AHA enthusiastically support the
change in direction that the NHLBI is taking, and we are
pleased to partner in this important venture in service to thehealth of the public. We are proud of our ability to generate
CPGs that have been shown to improve the cardiovascu-
lar health of patients. We pledge to be objective, diligent,
thorough, collaborative, and clinically relevant in this
process. We furthermore pledge to devote all the resources
necessary to complete this effort in a timeframe that is both
efﬁcient and sufﬁcient for the production of quality products
of superior utility for the beneﬁt of our citizens.REFERENCES
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